Innovations in blood pressure measurement and reporting technology: International Society of Hypertension position paper endorsed by the World Hypertension League, European Society of Hypertension, Asian Pacific Society of Hypertension, and Latin American Society of Hypertension.
Autor: | Kario K; Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan., Williams B; University College London (UCL) and National Insitute for Health Research UCL Hospitals Biomedical Research Centre, London, United Kingdom., Tomitani N; Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan., McManus RJ; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom., Schutte AE; School of Population Health, University of New South Wales; The George Institute for Global Health, Sydney, Australia., Avolio A; Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia., Shimbo D; Hypertension Lab, Columbia University Irving Medical Center, New York, NY, USA., Wang JG; Centre for Epidemiological Studies and Clinical Trials, Shanghai Key Laboratory of Hypertension, Department of Hypertension, Ruijin Hospital, The Shanghai Institute of Hypertension, Shanghai Jiaotong University School of Medicine, Shanghai, China., Khan NA; Center for Advancing Health Outcomes, Department of Medicine, University of British Columbia, Vancouver, Canada., Picone DS; School of Health Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.; Menzies Institute for Medical Research, University of Tasmania, Tasmania, Australia., Tan I; The George Institute for Global Health, University of New South Wales, Sydney, Australia., Charlton PH; Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom., Satoh M; Division of Public Health, Hygiene and Epidemiology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan., Mmopi KN; Department of Biomedical Sciences, Faculty of Medicine. University of Botswana, Gaborone, Botswana., Lopez-Lopez JP; Masira Research Institute, Medical School, Universidad de Santander, Bucaramanga, Colombia., Bothe TL; Charité - Universitätsmedizin Berlin, Institute of Physiology, Center for Space Medicine and Extreme Environments Berlin, Berlin, Germany., Bianchini E; Institute of Clinical Physiology, Italian National Research Council, Pisa, Italy., Bhandari B; Department of Global Health and Population, Harvard T H Chan School of Public Health, Boston, MA, USA., Lopez-Rivera J; Unidad de Hipertension arterial, V departamento, Hospital Central San Cristobal, Tachira, Venezuela., Charchar FJ; Health Innovation and Transformation Centre, Federation University Australia, Ballarat.; Department of Physiology, University of Melbourne, Melbourne, Australia.; Department of Cardiovascular Sciences, University of Leicester, Leicester., Tomaszewski M; Division of Cardiovascular Sciences, Faculty of Medicine, Biology and Health, University of Manchester, Manchester.; Manchester Royal Infirmary, Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust, Manchester, United Kingdom., Stergiou G; Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, School of Medicine, Third Department of Medicine, Sotiria Hospital, Athens, Greece. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of hypertension [J Hypertens] 2024 Nov 01; Vol. 42 (11), pp. 1874-1888. Date of Electronic Publication: 2024 Sep 09. |
DOI: | 10.1097/HJH.0000000000003827 |
Abstrakt: | Blood pressure (BP) is a key contributor to the lifetime risk of preclinical organ damage and cardiovascular disease. Traditional clinic-based BP readings are typically measured infrequently and under standardized/resting conditions and therefore do not capture BP values during normal everyday activity. Therefore, current hypertension guidelines emphasize the importance of incorporating out-of-office BP measurement into strategies for hypertension diagnosis and management. However, conventional home and ambulatory BP monitoring devices use the upper-arm cuff oscillometric method and only provide intermittent BP readings under static conditions or in a limited number of situations. New innovations include technologies for BP estimation based on processing of sensor signals supported by artificial intelligence tools, technologies for remote monitoring, reporting and storage of BP data, and technologies for BP data interpretation and patient interaction designed to improve hypertension management ("digital therapeutics"). The number and volume of data relating to new devices/technologies is increasing rapidly and will continue to grow. This International Society of Hypertension position paper describes the new devices/technologies, presents evidence relating to new BP measurement techniques and related indices, highlights standard for the validation of new devices/technologies, discusses the reliability and utility of novel BP monitoring devices, the association of these metrics with clinical outcomes, and the use of digital therapeutics. It also highlights the challenges and evidence gaps that need to be overcome before these new technologies can be considered as a user-friendly and accurate source of novel BP data to inform clinical hypertension management strategies. (Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |